GlassScriptPhysician profile
Judith Lisa Kennedy
NPI 1790963494
$1,709.36
in general payments reported to CMS, 2019-2025
28 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $31.04 · 2021: $223 · 2022: $480 · 2023: $336 · 2024: $264 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $400.17 | 2021-2025 | Ova1 |
| Organon LLC | $171.80 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $149.40 | 2019-2021 | |
| Exeltis, USA INC. | $142.72 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $128.21 | 2023-2024 | Veozah |
| Pfizer INC. | $113.00 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $106.36 | 2022-2024 | |
| Coopersurgical, INC. | $92.65 | 2019-2025 | Paragard T 380a, Sos |
| Meditrina | $37.12 | 2022-2024 | |
| Medtronic, INC. | $36.67 | 2022 | |
| Hologic Sales and Service, LLC | $33.48 | 2023-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Amag Pharmaceuticals, INC. | $28.03 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.46 | 2022-2023 | |
| Duchesnay USA Incorporated | $24.66 | 2019 | |
| Sumitomo Pharma America, INC. | $21.74 | 2025 | Gemtesa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $19.49 | 2022 | |
| Dexcom, INC. | $19.20 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $18.62 | 2022 | |
| Gynesonics, INC. | $17.15 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.90 | 2022 | |
| Merck Sharp & Dohme LLC | $14.89 | 2024 | Gardasil, Gardasil 9 |
| Davol INC. | $14.56 | 2025 | Arista |
| Biogen, INC. | $14.53 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $13.30 | 2021 | |
| Amgen INC. | $13.26 | 2023 | Prolia, Evenity |
| Minerva Surgical, INC | $13.26 | 2023 | |
| Mallinckrodt Enterprises LLC | $12.66 | 2019 | |
| Lupin INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.